IMPURITIES AVAILABLE FOR 'Nintedanib'

Omsynth Lifesciences Pvt. Ltd. is one of the leading manufacturer and exporter of Nintedanib. Nintedanib is a small-molecule tyrosine kinase inhibitor (TKI) used for the treatment of idiopathic pulmonary fibrosis (IPF), systemic sclerosis-associated interstitial lung disease (SSc-ILD), and certain types of non-small cell lung cancer (NSCLC). It works by blocking multiple receptor tyrosine kinases, including VEGFR, FGFR, and PDGFR, which are involved in fibrosis and tumor angiogenesis. By inhibiting these pathways, nintedanib reduces fibroblast proliferation, extracellular matrix deposition, and vascular remodeling. It is administered orally, usually twice daily with food. The drug is metabolized mainly via esterases and excreted predominantly in feces. Common adverse effects include diarrhea, nausea, vomiting, and elevated liver enzymes. Rare but serious risks include hepatotoxicity and bleeding events. Nintedanib helps slow disease progression but does not reverse established fibrosis. Buy high quality Nintedanib from Omsynth Lifesciences.